Your session is about to expire
← Back to Search
Other
Tobacco cessation pharmacotherapy for Tobacco Cessation (Stepped Care Trial)
Phase 2 & 3
Waitlist Available
Led By Mark Vander Weg, PhD
Research Sponsored by Iowa City Veterans Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a new way to help Veterans quit smoking, which may be more effective than existing methods.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Tobacco cessation
Secondary study objectives
Salivary cotinine levels (in ng/ml)
Other study objectives
Level of satisfaction with the intervention as measured according to a five-point scale (extremely, very, moderately, slightly, not at all)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Tailored InterventionExperimental Treatment2 Interventions
Tailored behavioral counseling combined with tobacco cessation pharmacotherapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tailored behavioral counseling
2017
N/A
~30
Find a Location
Who is running the clinical trial?
Iowa City Veterans Affairs Medical CenterLead Sponsor
7 Previous Clinical Trials
2,414 Total Patients Enrolled
US Department of Veterans AffairsFED
873 Previous Clinical Trials
497,748 Total Patients Enrolled
Mark Vander Weg, PhDPrincipal InvestigatorIowa City VA Health Care System
Share this study with friends
Copy Link
Messenger